P4-ATPase subunit Cdc50 plays a role in yeast budding and cell wall integrity in Candida glabrata

被引:0
作者
Ke-Zhi Chen
Lu-Ling Wang
Jin-Yan Liu
Jun-Tao Zhao
Si-Jia Huang
Ming-Jie Xiang
机构
[1] Ruijin Hospital,Department of Laboratory Medicine
[2] Shanghai Jiao Tong University School of Medicine,Department of Laboratory Medicine
[3] Ruijin Hospital Luwan Branch,undefined
[4] Shanghai Jiao Tong University School of Medicine,undefined
来源
BMC Microbiology | / 23卷
关键词
Lipid flippase; Cdc50; Drug susceptibility; Cell wall integrity; Virulence;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 247 条
[1]  
Staniszewska M(2020)Virulence Factors in Candida species Curr Protein Pept Sci 21 313-323
[2]  
Kumar K(2019)Candida glabrata: A Lot More Than Meets the Eye Microorganisms. 7 39-305
[3]  
Askari F(2012)Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance FEMS Microbiol Rev 36 288-931
[4]  
Sahu MS(2018)The epidemiology and outcomes of invasive Candida infections among organ transplant recipients in the United States: results of the Transplant-Associated Infection Surveillance Network (TRANSNET) Invasive candidiasis Nat Rev Dis Primers 4 18026-10
[5]  
Kaur R(2016)Global trends in the distribution of Candida species causing candidemia Transpl Infect Dis 18 921-S147
[6]  
Silva S(2014)Distribution and Antifungal Susceptibility of Candida Species Causing Candidemia in China: An Update From the CHIF-NET Study Clin Microbiol Infect 20 5-iv54
[7]  
Negri M(2020)Species distribution and antifungal susceptibility of invasive Candida isolates from Canadian hospitals: results of the CANWARD 2011–16 study J Infect Dis 221 S139-1128
[8]  
Henriques M(2019)The epidemiology of hematogenous candidiasis caused by different Candida species J Antimicrob Chemother. 74 iv48-60
[9]  
Oliveira R(1997)Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance Clin Infect Dis 24 1122-e392
[10]  
Williams DW(2002)The global problem of antifungal resistance: prevalence, mechanisms, and management J Hosp Infect. 50 243-766